药占比-话题@MedSci

#药占比#

43篇内容 | 1031人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1509781, encodeId=4ddf1509e812b, content=<a href='/topic/show?id=1c8e8e333cb' target=_blank style='color:#2F92EE;'>#药占比#</a>, objectTitle=一批品种，不占药占比, objectType=article, longId=192403, objectId=dd2b19240309, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd2b19240309, replyNumber=0, likeNumber=37, createdTime=2020-04-18, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd2b19240309, moduleTitle=一批品种，不占药占比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd2b19240309)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509780, encodeId=ef3b1509e802d, content=<a href='/topic/show?id=1c8e8e333cb' target=_blank style='color:#2F92EE;'>#药占比#</a>, objectTitle=一批大品种或不占药占比, objectType=article, longId=178625, objectId=44b01e862540, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=44b01e862540, replyNumber=0, likeNumber=32, createdTime=2019-09-04, rootId=0, userName=HNYYM, userId=762710134609, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=44b01e862540, moduleTitle=一批大品种或不占药占比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=44b01e862540)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509779, encodeId=c5aa1509e7944, content=<a href='/topic/show?id=1c8e8e333cb' target=_blank style='color:#2F92EE;'>#药占比#</a>, objectTitle=一批大品种，或不占药占比, objectType=article, longId=178602, objectId=bac21e860287, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bac21e860287, replyNumber=0, likeNumber=30, createdTime=2019-09-04, rootId=0, userName=HNYYM, userId=762710134609, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bac21e860287, moduleTitle=一批大品种，或不占药占比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bac21e860287)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509778, encodeId=1e651509e7845, content=<a href='/topic/show?id=1c8e8e333cb' target=_blank style='color:#2F92EE;'>#药占比#</a>, objectTitle=处方药零售的两大挑战：医保支付价和药占比取消, objectType=article, longId=162639, objectId=7f0b16263918, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f0b16263918, replyNumber=0, likeNumber=39, createdTime=2019-03-21, rootId=0, userName=HNYYM, userId=762710134609, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f0b16263918, moduleTitle=处方药零售的两大挑战：医保支付价和药占比取消, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f0b16263918)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509777, encodeId=a7831509e7784, content=<a href='/topic/show?id=1c8e8e333cb' target=_blank style='color:#2F92EE;'>#药占比#</a>, objectTitle=药占比考核20年之怪现状, objectType=article, longId=162407, objectId=edf816240e96, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=edf816240e96, replyNumber=0, likeNumber=33, createdTime=2019-03-17, rootId=0, userName=HNYYM, userId=762710134609, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=edf816240e96, moduleTitle=药占比考核20年之怪现状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=edf816240e96)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509776, encodeId=6a1f1509e76a1, content=<a href='/topic/show?id=1c8e8e333cb' target=_blank style='color:#2F92EE;'>#药占比#</a>, objectTitle=药占比的下半场，会上演怎样的大戏？, objectType=article, longId=162081, objectId=d4fc1620813b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4fc1620813b, replyNumber=0, likeNumber=34, createdTime=2019-03-13, rootId=0, userName=HNYYM, userId=762710134609, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4fc1620813b, moduleTitle=药占比的下半场，会上演怎样的大戏？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4fc1620813b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509775, encodeId=0fb71509e7587, content=<a href='/topic/show?id=1c8e8e333cb' target=_blank style='color:#2F92EE;'>#药占比#</a>, objectTitle=药占比大变革，药企机会来了, objectType=article, longId=160180, objectId=613316018019, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=613316018019, replyNumber=0, likeNumber=31, createdTime=2019-02-18, rootId=0, userName=HNYYM, userId=762710134609, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=613316018019, moduleTitle=药占比大变革，药企机会来了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=613316018019)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509774, encodeId=011a1509e740b, content=<a href='/topic/show?id=1c8e8e333cb' target=_blank style='color:#2F92EE;'>#药占比#</a>, objectTitle=药占比大变革药企机会来了, objectType=article, longId=160069, objectId=6234160069b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6234160069b8, replyNumber=0, likeNumber=36, createdTime=2019-02-16, rootId=0, userName=HNYYM, userId=762710134609, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6234160069b8, moduleTitle=药占比大变革药企机会来了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6234160069b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509773, encodeId=57ce1509e73c8, content=<a href='/topic/show?id=1c8e8e333cb' target=_blank style='color:#2F92EE;'>#药占比#</a>, objectTitle=取消药占比，精细化控费仍在路上, objectType=article, longId=159947, objectId=a86a15994e62, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a86a15994e62, replyNumber=0, likeNumber=41, createdTime=2019-02-15, rootId=0, userName=HNYYM, userId=762710134609, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a86a15994e62, moduleTitle=取消药占比，精细化控费仍在路上, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a86a15994e62)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509772, encodeId=41591509e726f, content=<a href='/topic/show?id=1c8e8e333cb' target=_blank style='color:#2F92EE;'>#药占比#</a>, objectTitle=国家卫健委：4+7中标品种不受药占比、一品两规限制, objectType=article, longId=159170, objectId=ac5a1591e0d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ac5a1591e0d6, replyNumber=0, likeNumber=39, createdTime=2019-01-31, rootId=0, userName=HNYYM, userId=762710134609, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ac5a1591e0d6, moduleTitle=国家卫健委：4+7中标品种不受药占比、一品两规限制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ac5a1591e0d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509771, encodeId=a5471509e7173, content=<a href='/topic/show?id=1c8e8e333cb' target=_blank style='color:#2F92EE;'>#药占比#</a>, objectTitle=30个药不占药占比, objectType=article, longId=158780, objectId=8c1d158e80b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c1d158e80b9, replyNumber=0, likeNumber=36, createdTime=2019-01-26, rootId=0, userName=HNYYM, userId=762710134609, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c1d158e80b9, moduleTitle=30个药不占药占比, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c1d158e80b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509770, encodeId=1b891509e7061, content=<a href='/topic/show?id=1c8e8e333cb' target=_blank style='color:#2F92EE;'>#药占比#</a>, objectTitle=国家医保局：一品两规、药占比应适度调整, objectType=article, longId=158448, objectId=355215844806, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=355215844806, replyNumber=0, likeNumber=38, createdTime=2019-01-21, rootId=0, userName=HNYYM, userId=762710134609, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=355215844806, moduleTitle=国家医保局：一品两规、药占比应适度调整, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=355215844806)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509769, encodeId=630b1509e69ee, content=<a href='/topic/show?id=1c8e8e333cb' target=_blank style='color:#2F92EE;'>#药占比#</a>, objectTitle=控药占比药费不降反升，按病种付费才是降费之道？！, objectType=article, longId=155308, objectId=9dd615530863, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9dd615530863, replyNumber=0, likeNumber=34, createdTime=2018-12-08, rootId=0, userName=HNYYM, userId=762710134609, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9dd615530863, moduleTitle=控药占比药费不降反升，按病种付费才是降费之道？！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9dd615530863)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509768, encodeId=da711509e68d4, content=<a href='/topic/show?id=1c8e8e333cb' target=_blank style='color:#2F92EE;'>#药占比#</a>, objectTitle=三部门：不得以费用总控、药占比等为理由影响谈判药品供应, objectType=article, longId=154806, objectId=c4a815480684, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4a815480684, replyNumber=0, likeNumber=39, createdTime=2018-12-02, rootId=0, userName=HNYYM, userId=762710134609, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4a815480684, moduleTitle=三部门：不得以费用总控、药占比等为理由影响谈判药品供应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4a815480684)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509767, encodeId=ea521509e6783, content=<a href='/topic/show?id=1c8e8e333cb' target=_blank style='color:#2F92EE;'>#药占比#</a>, objectTitle=国家医保局发通知，这些药不占药占比！, objectType=article, longId=154748, objectId=5ab1154e485b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ab1154e485b, replyNumber=0, likeNumber=25, createdTime=2018-12-01, rootId=0, userName=HNYYM, userId=762710134609, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ab1154e485b, moduleTitle=国家医保局发通知，这些药不占药占比！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ab1154e485b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509766, encodeId=19c01509e66dc, content=<a href='/topic/show?id=1c8e8e333cb' target=_blank style='color:#2F92EE;'>#药占比#</a>, objectTitle=卫健委：谈判抗癌药不纳入药占比不落实省份和医院将被通报, objectType=article, longId=154107, objectId=293d15410ecf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=293d15410ecf, replyNumber=0, likeNumber=25, createdTime=2018-11-23, rootId=0, userName=HNYYM, userId=762710134609, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=293d15410ecf, moduleTitle=卫健委：谈判抗癌药不纳入药占比不落实省份和医院将被通报, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=293d15410ecf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509765, encodeId=f60b1509e65c0, content=<a href='/topic/show?id=1c8e8e333cb' target=_blank style='color:#2F92EE;'>#药占比#</a>, objectTitle=基药不占药占比了，配备比例大增！, objectType=article, longId=152971, objectId=f4521529e14d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4521529e14d, replyNumber=0, likeNumber=45, createdTime=2018-11-09, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4521529e14d, moduleTitle=基药不占药占比了，配备比例大增！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4521529e14d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509764, encodeId=f8ce1509e64d6, content=<a href='/topic/show?id=1c8e8e333cb' target=_blank style='color:#2F92EE;'>#药占比#</a>, objectTitle=药占比考核不会取缔综合指数绩效考核或更合理, objectType=article, longId=152310, objectId=4729152310fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4729152310fc, replyNumber=0, likeNumber=27, createdTime=2018-10-31, rootId=0, userName=HNYYM, userId=762710134609, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4729152310fc, moduleTitle=药占比考核不会取缔综合指数绩效考核或更合理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4729152310fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509763, encodeId=3eb51509e63a6, content=<a href='/topic/show?id=1c8e8e333cb' target=_blank style='color:#2F92EE;'>#药占比#</a>, objectTitle=药占比将会取消？业内专家是这样说的, objectType=article, longId=151614, objectId=216315161409, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=216315161409, replyNumber=0, likeNumber=39, createdTime=2018-10-24, rootId=0, userName=HNYYM, userId=762710134609, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=216315161409, moduleTitle=药占比将会取消？业内专家是这样说的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=216315161409)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1509762, encodeId=e52e1509e6200, content=<a href='/topic/show?id=1c8e8e333cb' target=_blank style='color:#2F92EE;'>#药占比#</a>, objectTitle=取消药占比考核细思之后医院压力更大？, objectType=article, longId=151507, objectId=bfcf15150ec8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bfcf15150ec8, replyNumber=0, likeNumber=35, createdTime=2018-10-23, rootId=0, userName=HNYYM, userId=762710134609, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bfcf15150ec8, moduleTitle=取消药占比考核细思之后医院压力更大？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bfcf15150ec8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

药占比

2020-05-29

仁者大医 (审核中...)

前往app查看评论内容

#药占比#

一批品种，不占药占比

2020-04-18

HNYYM (审核中...)

前往app查看评论内容

#药占比#

一批大品种或不占药占比

2019-09-04

HNYYM (审核中...)

前往app查看评论内容

#药占比#

一批大品种，或不占药占比

2019-09-04

HNYYM (审核中...)

前往app查看评论内容

#药占比#

处方药零售的两大挑战：医保支付价和药占比取消

2019-03-21

HNYYM (审核中...)

前往app查看评论内容

#药占比#

药占比考核20年之怪现状

2019-03-17

HNYYM (审核中...)

前往app查看评论内容

#药占比#

药占比的下半场，会上演怎样的大戏？

2019-03-13

HNYYM (审核中...)

前往app查看评论内容

#药占比#

药占比大变革，药企机会来了

2019-02-18

HNYYM (审核中...)

前往app查看评论内容

#药占比#

药占比大变革药企机会来了

2019-02-16

HNYYM (审核中...)

前往app查看评论内容

#药占比#

取消药占比，精细化控费仍在路上

2019-02-15

HNYYM (审核中...)

前往app查看评论内容

#药占比#

国家卫健委：4+7中标品种不受药占比、一品两规限制

2019-01-31

HNYYM (审核中...)

前往app查看评论内容

#药占比#

30个药不占药占比

2019-01-26

HNYYM (审核中...)

前往app查看评论内容

#药占比#

国家医保局：一品两规、药占比应适度调整

2019-01-21

HNYYM (审核中...)

前往app查看评论内容

#药占比#

控药占比药费不降反升，按病种付费才是降费之道？！

2018-12-08

HNYYM (审核中...)

前往app查看评论内容

#药占比#

三部门：不得以费用总控、药占比等为理由影响谈判药品供应

2018-12-02

HNYYM (审核中...)

前往app查看评论内容

#药占比#

国家医保局发通知，这些药不占药占比！

2018-12-01

HNYYM (审核中...)

前往app查看评论内容

#药占比#

卫健委：谈判抗癌药不纳入药占比不落实省份和医院将被通报

2018-11-23

柳叶一刀 (审核中...)

前往app查看评论内容

#药占比#

基药不占药占比了，配备比例大增！

2018-11-09

HNYYM (审核中...)

前往app查看评论内容

#药占比#

药占比考核不会取缔综合指数绩效考核或更合理

2018-10-31

HNYYM (审核中...)

前往app查看评论内容

#药占比#

药占比将会取消？业内专家是这样说的

2018-10-24

HNYYM (审核中...)

前往app查看评论内容

#药占比#

取消药占比考核细思之后医院压力更大？

2018-10-23

科室
- - 订阅+
  - 更多科室
工具
服务